Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesMolecular ImagingPSMA PET-guided radiotherapy shows promiseA trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.Practice ManagementContrast media-reduction strategies could curb emissions up to 53%Practice ManagementDoes CMS 2026 proposed rule enforce efficiency at a cost to practices?Womens ImagingMissed previous mammography screening linked to worse disease outcomesSponsor ContentDigital Innovations Shaping the Future of Radiology
